Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy
Am J Ophthalmol
.
2021 Feb:222:397-398.
doi: 10.1016/j.ajo.2020.10.005.
Epub 2020 Nov 12.
Authors
Thomas J van Rijssen
1
,
Elon H C van Dijk
1
,
Greet Dijkman
1
,
Roula Tsonaka
1
,
Paula Scholz
2
,
Myrte B Breukink
3
,
Carel B Hoyng
3
,
Petrus J H Peters
4
,
Robert E MacLaren
5
,
Susan M Downes
5
,
Sascha Fauser
6
,
Camiel J F Boon
7
Affiliations
1
Leiden, the Netherlands.
2
Cologne, Germany.
3
Nijmegen, the Netherlands.
4
Velp, the Netherlands.
5
Oxford, United Kingdom.
6
Cologne, Germany; Basel, Switzerland.
7
Leiden, the Netherlands; Amsterdam, the Netherlands.
PMID:
33188739
DOI:
10.1016/j.ajo.2020.10.005
No abstract available
Publication types
Letter
Comment
MeSH terms
Central Serous Chorioretinopathy* / diagnosis
Central Serous Chorioretinopathy* / drug therapy
Fluorescein Angiography
Humans
Lasers
Photochemotherapy*
Photosensitizing Agents / therapeutic use
Substances
Photosensitizing Agents